Ceretas
PrivateLast Round
Grant
Sep 22, 2025
Total Funding Raised
$3.4M
Company Overview
Ceretas is a healthtech company developing a non-invasive, safe, and portable therapeutic ultrasound platform to treat diseases of the brain, such as Alzheimer's disease.
Keywords
focused ultrasoundneuromodulationblood-brain barrier openingAlzheimer's treatmentFUStherapeutic medical deviceBBB openingneurodegenerative diseasetargeted drug deliverymedtechportable ultrasound devicenon-invasive treatmentbrain stimulationuniversity spin-outclinical trialsMedical Research Future FundMRFF
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ceretas Comps
Public and private peers based on sector, stage, and business model.
Ceretas Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 22, 2025 | ||||
| Seed | Feb 21, 2025 |
Ceretas Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sequoia Asset Management | Seed |
| CUREator | Grant |
| Medical Research Future Fund | Grant |
| Caravel Securities | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 22, 2025
$2.4M grant round from CUREator and MRFF.
- Feb 21, 2025
$1M round led by Ryan Laws and Sam Wetzler.
Ceretas Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ceretas's valuation, stock price, and market status.
